Industry Focus

A 742% spending surge for hepatitis C, pricey new diabetes medications, and one new drug class that has payers nervous -- all discussed today by healthcare analyst Michael Douglass and healthcare contributor Todd Campbell on today's Industry Focus.

Direct download: 150318_IF_Healthcare.mp3
Category:Podcast -- posted at: 5:57pm EST

1